No Detail Found!

Efficacy and safety of optilume; a drug-coated balloon treatment for anterior urethral stricture

Author(s)
Muhammad Rafiq Zaki Sharif Medical & Dental College,Lahore,Sharif Medical & Dental College,Sharif Medical City. Sharif Medical City Road, Off Raiwind Road, Jati Umra, Lahore 54000,Pakistan
Mujahid Hussain Sharif Medical & Dental College,Lahore,Sharif Medical & Dental College,Sharif Medical City. Sharif Medical City Road, Off Raiwind Road, Jati Umra, Lahore 54000,Pakistan
Jawad Akbar Department of Urology and Renal Transplant Sharif Medical & Dental College, Lahore,Pakistan
Malik Tahir Mehmood Sharif Medical & Dental College,Lahore,Sharif Medical & Dental College,Sharif Medical City. Sharif Medical City Road, Off Raiwind Road, Jati Umra, Lahore 54000,Pakistan
Umar Lone Sharif Medical & Dental College,Lahore,Sharif Medical & Dental College,Sharif Medical City. Sharif Medical City Road, Off Raiwind Road, Jati Umra, Lahore 54000,Pakistan
Muhammad Hamza Sharif Medical & Dental College,Lahore,Sharif Medical & Dental College,Sharif Medical City. Sharif Medical City Road, Off Raiwind Road, Jati Umra, Lahore 54000,Pakistan
Abstract
Objective: To determine the efficacy and safety of Optilume; a drug-coated balloon (DCB) treatment for anterior urethral strictures. Methodology: This multi-centered descriptive case series study was carried out in the Department of Urology and Renal Transplant, Sharif Medical City Hospital, Lahore and the Department of Urology, National Hospital & Medical Center, Lahore on thirty cases presenting with =3 cm strictures in the anterior urethra. This study was conducted from November 2021 to October 2022. Follow-up was done at two weeks, 3 months, 6 months, and one year. The primary efficacy endpoint was an improvement in International Prostate Symptom Score (IPSS), secondary outcomes included post micturition residual urine (PMRU), maximum urinary flow rate (Qmax), the International Index of Erectile Function (IIEF), and quality of life. The variables were analyzed by computer-based software and descriptive statistics were used to present the outcomes. Results: A total of 30 patients were treated with Optilume DCB, 13(43%) patients completed one year follow-up and 17(56%) completed 6 months follow-up. Eighteen (60%) patients had a history of endoscopic treatment. There were no treatment-related side effects after one year of treatment. Success was achieved in 100% at a mean follow-up of 8.4 months and the baseline mean change in IPSS score was 18 at one year. Quality of life, Qmax flow rate, and PMRU improved significantly from the baseline. Conclusion: One year treatment data shows that Optilume DCB is safe and effective for the treatment of recurrent strictures of the anterior urethra as it showed a significant improvement in the present study.
Publication Details
Page(s) 77-80
DOI DOI not available
Published Journal: Journal of Sharif Medical & Dental College (JSMDC), Volume: 8, Issue: 2, Year: 2022

Request the full text from PASTIC

Keywords
Anterior urethral strictures, Quality of life International Prostate Symptom Score
0

Citations

0

Downloads

109

Views